Recce Pharmaceuticals (ASX:RCE) has entered into a Cooperative Research and Development Agreement with the US Army Medical Research Institute of Infectious Diseases, with partnership and funding from the Defense Threat Reduction Agency. …
Latest Video
New Stories
-
Recce Pharmaceuticals enters research and development agreement with US defence
April 28, 2025 - -
Radiopharm Theranostics doses first patient in US Phase 2b imaging study of brain metastasis
April 28, 2025 - - Australian Biotech -
Dimerix says FDA confirms proteinuria as acceptable endpoint for DMX-200 Phase 3 trial
April 28, 2025 - - Australian Biotech -
Government funding for new nasal spray ends three-decade drought
April 27, 2025 - - Latest News -
Repurposed diabetes drug could deliver gains for people living with major joint pain
April 27, 2025 - - Latest News -
March PBAC delivers outcome for high profile pre-funded cancer therapy
April 27, 2025 - - Latest News -
TGA approves new indication for GSK's RSV vaccine
April 24, 2025 - - Latest News